Home / Riluzole / United States
US ATC N07XX02 · updated 2 Nov 2026
Riluzole shortage in United States
Is there a Riluzole shortage in United States?
Yes. As of 2 Nov 2026, 4 Riluzole products are reported short in United States, the first since 26 Jan 2024. No return date has been given. Main reason: not stated.
Also short in Canada, France, Italy, Austria, Australia. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0304-1) | EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.) | 26 Jan 2024 | not given | Not stated |
| US | Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0305-1) | EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.) | 26 Jan 2024 | not given | Not stated |
| US | Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0306-1) | EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.) | 26 Jan 2024 | not given | Not stated |
| US | Tiglutik, Oral Suspension, 50 mg/10 mL (NDC 70726-0303-1) | EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.) | 26 Jan 2024 | not given | Manufacturing problem Requirements related to complying with good manufacturing practices |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).